Proteome Sciences plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PMSNF research report →
About the company
Proteome Sciences Plc is a provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. It offers proprietary technologies for protein and peptide biomarker discovery, validation, and assay development. The company focuses on developing proprietary protein biomarkers for neurological diseases, oncology, and organ transplant rejection.
- CEO
- Jon Faber
- IPO
- 2010
- Employees
- 36
- HQ
- Cobham, AB, GB
Price Chart
- Market Cap
- $5.78M
- P/E
- -1.56
- P/S
- 1.25
- P/B
- -0.50
- EV/EBITDA
- -11.31
- Div Yield
- 0.00%
- Gross Margin
- -26.81%
- Op Margin
- -70.98%
- Net Margin
- -81.50%
- ROE
- 33.80%
- ROIC
- -34.27%
- Revenue
- $3.76M · -23.14%
- Net Income
- $-3,060,503 · 10.12%
- EPS
- $-0.01 · 9.57%
- Op Income
- $-2,624,574
- FCF YoY
- 86.38%
- 52W High
- $0.08
- 52W Low
- $0.01
- 50D MA
- $0.04
- 200D MA
- $0.04
- Beta
- 0.15
- Avg Volume
- 49
Get TickerSpark's AI analysis on PMSNF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PMSNF coverage
Recent articles, reports, and earnings notes.
No research on PMSNF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PMSNF report →Similar companies
Peers in the same neighborhood.